Clinical Trial Update: A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z [Phase 1]

View source ↗

Summary

The Phase I trial evaluating the Ebola vaccines cAd3-EBO Z and MVA-EBO Z conducted by the University of Oxford has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• MVA-EBO Z
• cAd3-EBO Z

Snippet

Sponsor: University of Oxford | Conditions: Ebola Virus Disease | Phase 1 | Status: TERMINATED